In Vivo CAR T-Cell Therapeutics With Umoja Biopharma's Dr. Andrew Scharenberg
Cell & Gene: The Podcast
00:00
Plans and Expectations for Umoja Biopharma in 2024
Umoja Biopharma discusses their goals for the year, including executing on their series B plan, advancing their platforms, generating clinical data, and consolidating their operations.
Transcript
Play full episode
